The Company's stock-based compensation plans are described in Note 13, Stock-Based Compensation Plans, to the consolidated financial statements in the 2025 Form 10-K. In general, restricted stock units awarded to executive officers and other employees vest ratably over a period of three years. Subject to the achievement of performance targets established by the Compensation Committee of the Company's Board of Directors (the "Board"), performance stock units vest after a period of three years.

Information for restricted stock units and performance stock units accounted for as equity awards during the nine months ended May 31, 2026 is as follows:


	Shares	Weighted Average Fair Value
Outstanding as of August 31, 2025	1,369,205	$	50.37
Granted	770,033	63.88
Vested	(768,951)	48.40
Forfeited	(75,767)	58.31
Outstanding as of May 31, 2026	1,294,520	$	59.12

The Company granted 107,771 equivalent shares in the form of restricted stock units and performance stock units accounted for as liability awards during the nine months ended May 31, 2026. As of May 31, 2026, the Company had outstanding 256,100 equivalent shares accounted for under the liability method. The Company expects 247,059 equivalent shares to vest.

Total stock-based compensation expense, including fair value remeasurements, which was primarily included in SG&A expenses in the condensed consolidated statements of earnings (loss), was $11.4 million and $37.4 million for the three and nine months ended May 31, 2026, respectively, and was $9.5 million and $27.8 million for the three and nine months ended May 31, 2025, respectively.